Scholar Rock will present new Phase 3 SAPPHIRE trial data on apitegromab at the 2025 MDA conference, highlighting efficacy ...

Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract ...

Changes are coming to Mega Millions in 2025 that make it easier to win a non-jackpot prize, although these shifts involve one ...

My current strategy combines dividend growth investing with Big Picture research. Check out my take on the 10 Rules of ...

Even if they go mostly unnoticed, industrial businesses are the backbone of our country. Still, their generally high capital ...

U.S. stocks advanced on Wednesday as cooler-than-expected inflation data helped stanch a sharp selloff, while the escalation ...

Bitcoin price rose 3% in the last 24 hours, reclaiming territories above $83,700 after forming a local bottom around $76,000 ...

We use our proprietary models to rate stocks quantitatively and qualitatively. Read here for an analysis of our top picks in ...

Cranberry juice not only tastes great; it's also packed with nutrients to keep you healthy. Research suggests it may prevent some unexpected diseases, too.

"The supply/demand dynamic is a headwind for the muni market this week as supply is expected to be elevated," said Cooper ...